Cargando…

Influence of anticancer agents on sexual function: An in vivo study based on the US FDA Adverse Event Reporting System

BACKGROUND: Patients with cancer are treated with chemotherapeutics that cause adverse effects, including erectile dysfunction (ED). OBJECTIVES: We investigated erectile function in rats after the administration of anticancer agents based on data retrieved through mining of the US Food and Drug Admi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kataoka, Tomoya, Sanagawa, Akimasa, Suzuki, Jun, Muto, Tatsuya, Hotta, Yuji, Kawade, Yoshihiro, Maeda, Yasuhiro, Tohkin, Masahiro, Kimura, Kazunori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291990/ https://www.ncbi.nlm.nih.gov/pubmed/34390622 http://dx.doi.org/10.1111/andr.13094

Ejemplares similares

Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System
por: Sanagawa, Akimasa, et al.
Publicado: (2018)

Effect of High Testosterone Levels on Endothelial Function in Aorta and Erectile Function in Rats
por: Kataoka, Tomoya, et al.
Publicado: (2022)

Gosha-Jinki-Gan Improved Erectile Dysfunction Caused by Anti-Cancer Agent Oxaliplatin by Decreasing Transcriptional Expression of Phosphodiesterase-5 in Rats
por: Kataoka, Tomoya, et al.
Publicado: (2022)

Evaluating the Effects of Low Carbohydrate and High Protein Diet on Erectile Function in Rats
por: Kataoka, Tomoya, et al.
Publicado: (2022)

Clinical Usefulness of the “MN Criteria” - the Clostridioides difficile Infection Severity Scoring System - in the Japanese Setting
por: Asaoka, Minami, et al.
Publicado: (2022)

Light-controlled relaxation of the rat penile corpus cavernosum using NOBL-1, a novel nitric oxide releaser
por: Hotta, Yuji, et al.
Publicado: (2016)

Bortezomib administration is a risk factor associated with the development of tumor lysis syndrome in male patients with multiple myeloma: a retrospective study
por: Kondo, Masahiro, et al.
Publicado: (2020)

The Relationship between Changes in Serum Element Concentrations and Pathological Condition and Disease Status in Japanese Multiple Myeloma Patients: A Pilot Study and Literature Review
por: Yamamoto, Yuko, et al.
Publicado: (2023)

A review of experimental techniques for erectile function researches and development of medical technology using animal erectile dysfunction models in sexual and reproductive medicine
por: Kataoka, Tomoya, et al.
Publicado: (2023)

Outcomes of the implementation of the computer-assisted HBView system for the prevention of hepatitis B virus reactivation in chemotherapy patients: a retrospective analysis
por: Sanagawa, Akimasa, et al.
Publicado: (2015)

Changes in zinc and manganese concentrations in cisplatin-induced acute kidney injury
por: Yamamoto, Yuko, et al.
Publicado: (2023)

Effect of Late Androgen Replacement Therapy on Erectile Function Through Structural Changes in Castrated Rats
por: Kataoka, Tomoya, et al.
Publicado: (2021)

Effects of High Salt Intake on Detrusor Muscle Contraction in Dahl Salt-Sensitive Rats
por: Kawata, Ryoya, et al.
Publicado: (2021)

The phosphodiesterase 5 inhibitor tadalafil has renoprotective effects in a rat model of chronic kidney disease
por: Tomita, Natsumi, et al.
Publicado: (2020)

Enhancement of the RhoA/Rho kinase pathway is associated with stress‐related erectile dysfunction in a restraint water immersion stress model
por: Mori, Taiki, et al.
Publicado: (2021)

Efficacy of a Red-Light Controllable Nitric Oxide Releaser for Neurogenic Erectile Dysfunction: A Study Using a Rat Model of Cavernous Nerve Injury
por: Mori, Taiki, et al.
Publicado: (2023)

In Silico Approach to Predict Severe Cutaneous Adverse Reactions Using the Japanese Adverse Drug Event Report Database
por: Ambe, Kaori, et al.
Publicado: (2021)

Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System
por: Fusaroli, Michele, et al.
Publicado: (2022)

Hypersensitivity reactions to anticancer agents: Data mining of the public version of the FDA adverse event reporting system, AERS
por: Kadoyama, Kaori, et al.
Publicado: (2011)

A systematic analysis of FDA-approved anticancer drugs
por: Sun, Jingchun, et al.
Publicado: (2017)

Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
por: Sonawane, Kalyani B., et al.
Publicado: (2018)

ISS-N1 makes the First FDA-approved Drug for Spinal Muscular Atrophy
por: Ottesen, Eric W.
Publicado: (2017)

Radiation eye dose to medical staff during respiratory endoscopy under X-ray fluoroscopy
por: Haga, Yoshihiro, et al.
Publicado: (2020)

Syndrome of Inappropriate Secretion of Antidiuretic Hormone Caused by Carboplatin After Switching from Cisplatin in a Metastatic Urethral Cancer Patient
por: Sugiyama, Yosuke, et al.
Publicado: (2017)

Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database
por: Kan, Yusuke, et al.
Publicado: (2021)

Change in the central control of the bladder function of rats with focal cerebral infarction induced by photochemically-induced thrombosis
por: Ota, Yuya, et al.
Publicado: (2021)

Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System
por: Raschi, Emanuel, et al.
Publicado: (2022)

2172. Assessment of Cefepime Neurotoxicity in the FDA Adverse Reporting System
por: Groff, Lindsey, et al.
Publicado: (2018)

Cognitive clustering in schizophrenia patients, their first-degree relatives and healthy subjects is associated with anterior cingulate cortex volume
por: Ohi, Kazutaka, et al.
Publicado: (2017)

Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
por: Li, Ying, et al.
Publicado: (2020)

Assessing taxane-associated adverse events using the FDA adverse event reporting system database
por: Lao, Dong-Hui, et al.
Publicado: (2021)

Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs
por: Sun, Ren, et al.
Publicado: (2013)

Data Mining of the Public Version of the FDA Adverse Event Reporting System
por: Sakaeda, Toshiyuki, et al.
Publicado: (2013)

Investigation of tolerability and quality of life for carboplatin-based chemotherapy in an elderly urothelial carcinoma patient undergoing hemodialysis: a case report
por: Kondo, Masahiro, et al.
Publicado: (2018)

Safety comparisons among monoamine oxidase inhibitors against Parkinson’s disease using FDA adverse event reporting system
por: Asano, Hiroto, et al.
Publicado: (2023)

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
por: Zou, Shu-peng, et al.
Publicado: (2023)

Repair kinetics of DNA double-strand breaks and incidence of apoptosis in mouse neural stem/progenitor cells and their differentiated neurons exposed to ionizing radiation
por: Kashiwagi, Hiroki, et al.
Publicado: (2018)

Real‐world evidence of population differences in allopurinol‐related severe cutaneous adverse reactions in East Asians: A population‐based cohort study
por: Sato, Tsugumichi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5f1o27bc3f1qf7ftd6pkb0nbs6